Compare PETS & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PETS | RDI |
|---|---|---|
| Founded | 1996 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Movies/Entertainment |
| Sector | Consumer Staples | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7M | 36.6M |
| IPO Year | 2003 | 1994 |
| Metric | PETS | RDI |
|---|---|---|
| Price | $1.76 | $1.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 112.7K | 67.5K |
| Earning Date | 06-09-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.76 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $273,800,000.00 | $202,988,000.00 |
| Revenue This Year | N/A | $16.25 |
| Revenue Next Year | $2.98 | $4.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.57 | $0.94 |
| 52 Week High | $4.10 | $1.78 |
| Indicator | PETS | RDI |
|---|---|---|
| Relative Strength Index (RSI) | 35.34 | 76.62 |
| Support Level | $1.70 | $1.00 |
| Resistance Level | $1.87 | N/A |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 16.18 | 97.83 |
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.